Alkermes (ALKS) Revenue (2010 - 2026)
Alkermes (ALKS) recorded Revenue of $496.01 million in Q2 2026, up 27.0% from $390.66 million a year earlier and up 26.2% from the prior quarter.
Powered by 
Analysis
Alkermes (ALKS) Revenue (2010 - 2026) Analysis & Trends
On a TTM basis, Alkermes' Revenue came in at $1.67 billion as of Jun 30, 2026, up 10.8% year-over-year; for FY2025, it was $1.48 billion, down 5.2% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $1.56 billion in FY2024 (-6.4%), $1.66 billion in FY2023 (+49.6%), $1.11 billion in FY2022 (-5.3%) and $1.17 billion in FY2021 (+13.0%).
- The Q2 2026 figure is the highest quarterly Revenue since Q2 2023.
- On a year-over-year basis, Revenue rose in four of the last eight quarters, with growth averaging 5.9%.
- Peak year-over-year performance for Revenue in the last five years was growth of 123.5% in Q2 2023, against a decline of 35.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $392.91 million (Q1 2026), $384.55 million (Q4 2025) and $394.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Alkermes | 6.79 Bn | 3.92 Bn | 397.90 Mn | 496.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 496.01 Mn |
| Mar 31, 2026 | 392.91 Mn |
| Dec 31, 2025 | 384.55 Mn |
| Sep 30, 2025 | 394.19 Mn |
| Jun 30, 2025 | 390.66 Mn |
| Mar 31, 2025 | 306.51 Mn |
| Dec 31, 2024 | 429.99 Mn |
| Sep 30, 2024 | 378.14 Mn |
| Jun 30, 2024 | 399.13 Mn |
| Mar 31, 2024 | 350.37 Mn |
| Dec 31, 2023 | 377.48 Mn |
| Sep 30, 2023 | 380.94 Mn |
| Jun 30, 2023 | 617.40 Mn |
| Mar 31, 2023 | 287.60 Mn |
| Dec 31, 2022 | 304.67 Mn |
| Sep 30, 2022 | 252.36 Mn |
| Jun 30, 2022 | 276.22 Mn |
| Mar 31, 2022 | 278.55 Mn |
| Dec 31, 2021 | 324.46 Mn |
| Sep 30, 2021 | 294.14 Mn |
API Access
Alkermes Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ALKS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();